SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0000947871-08-000374
Filing Date
2008-06-25
Accepted
2008-06-25 17:17:37
Documents
6
Filing Date Changed
2008-06-25
Group Members
ALKALOIDA CHEMICAL COMPANY EXCLUSIVE GROUP LTDSUN PHARMA GLOBAL INC.

Document Format Files

Seq Description Document Type Size
1 ss40909_sc13da.htm SC 13D/A 117346
2 ASSIGNMENT AND ASSUMPTION AGREEMENT ss40909_ex9920.htm EX-99.20 20145
3 NOTICE OF EXERCISE OF OPTIONS ss40909_ex9921.htm EX-99.21 52845
4 GRAPHIC ex9921.jpg GRAPHIC 1180
5 PRESS RELEASE ss40909_ex9922.htm EX-99.22 29371
6 GRAPHIC logo.jpg GRAPHIC 5423
  Complete submission text file 0000947871-08-000374.txt   231046
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49231 | Film No.: 08917297
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address SPARC AKOTA ROAD VADODARA K7 390020 01191228212128
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0001197089 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1